The FTC is challenging ‘junk’ drug patents. Here’s what they are and why they matter

The U.S. Federal Trade Commission (FTC) announced last week that it is, for the second time,…

Ozempic and 19 other drugs have ‘junk’ patents, the FTC says in a new challenge

The U.S. Federal Trade Commission (FDA) announced on Tuesday that it is disputing over 300 patent…